ImmuCell (ICCC) Short Interest Ratio & Short Volume

+0.01 (+0.20%)
(As of 04/22/2024 ET)

ImmuCell Short Interest Data

Current Short Volume
Previous Short Volume
Change Vs. Previous Month
Dollar Volume Sold Short
Short Interest Ratio / Days to Cover
Last Record Date
March 31, 2024
Outstanding Shares
Float Size
Short Percent of Float
Today's Trading Volume
Average Trading Volume
Today's Volume Vs. Average
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling ImmuCell ?

Sign up to receive the latest short interest report for ImmuCell and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ICCC Short Interest Over Time

ICCC Days to Cover Over Time

ICCC Percentage of Float Shorted Over Time

ImmuCell Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/20246,100 shares $32,330.00 -4.7%0.1%0.8 $5.30
3/15/20246,400 shares $33,600.00 +1.6%0.1%0.8 $5.25
2/29/20246,300 shares $33,075.00 -20.3%0.1%0.8 $5.25
2/15/20247,900 shares $39,697.50 +5.3%0.1%0.9 $5.03
1/31/20247,500 shares $39,825.00 -2.6%0.1%0.8 $5.31
1/15/20247,700 shares $39,347.00 -13.5%0.1%0.6 $5.11
12/31/20238,900 shares $45,301.00 +30.9%0.2%0.8 $5.09
12/15/20236,800 shares $31,144.00 +13.3%0.1%0.5 $4.58
11/30/20236,000 shares $27,240.00 -7.7%0.1%0.4 $4.54
11/15/20236,500 shares $32,825.00 -52.2%0.1%0.4 $5.05
10/31/202313,600 shares $68,680.00 +70.0%0.3%0.8 $5.05
10/15/20238,000 shares $40,160.00 -28.6%0.1%0.5 $5.02
9/30/202311,200 shares $59,806.88 +62.3%0.2%0.7 $5.34
9/15/20236,900 shares $36,984.00 +15.0%0.1%0.4 $5.36
8/31/20236,000 shares $27,660.00 No Change0.1%0.4 $4.61
8/15/20236,000 shares $29,700.00 -11.8%0.1%0.5 $4.95
7/31/20236,800 shares $36,924.00 +11.5%0.1%0.6 $5.43
7/15/20236,100 shares $31,049.00 -3.2%0.1%0.6 $5.09
6/30/20236,300 shares $31,500.00 No Change0.1%0.7 $5.00
6/15/20236,300 shares $34,713.00 -6.0%0.1%0.8 $5.51
5/31/20236,700 shares $31,959.00 -30.2%0.1%0.8 $4.77
5/15/20239,600 shares $47,712.00 No Change0.2%1.1 $4.97
10/31/202210,500 shares $84,105.00 -38.2%0.2%1.3 $8.01
10/15/202217,000 shares $133,620.00 +60.4%0.3%2 $7.86
9/30/202210,600 shares $79,288.00 +6.0%0.2%1.2 $7.48
9/15/202210,000 shares $75,700.00 +19.1%0.2%1.1 $7.57
8/31/20228,400 shares $61,236.00 +12.0%0.2%0.9 $7.29
8/15/20227,500 shares $60,450.00 -24.2%0.1%1 $8.06
7/31/20229,900 shares $86,922.00 +32.0%0.2%1.1 $8.78
7/15/20227,500 shares $63,000.00 -13.8%0.1%0.7 $8.40
6/30/20228,700 shares $75,603.00 +24.3%0.2%0.8 $8.69
6/15/20227,000 shares $56,840.00 +1.5%0.1%0.6 $8.12
5/31/20226,900 shares $55,959.00 No Change0.1%0.6 $8.11
5/15/20226,900 shares $55,959.00 -45.2%0.1%0.6 $8.11
4/30/202212,600 shares $122,724.00 +41.6%0.2%1.1 $9.74
4/15/20228,900 shares $79,655.00 -22.6%0.2%0.8 $8.95
3/31/202211,500 shares $110,975.00 +21.1%N/A1.1 $9.65
3/15/20229,500 shares $82,270.00 +50.8%0.2%0.9 $8.66
2/28/20226,300 shares $51,471.00 -24.1%0.1%0.6 $8.17
2/15/20228,300 shares $68,226.00 +38.3%0.2%0.7 $8.22
Incredible Opportunity to Retire FAST! (Ad)

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide

ICCC Short Interest - Frequently Asked Questions

What is ImmuCell's current short interest?

Short interest is the volume of ImmuCell shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 6,100 shares of ICCC short. 0.11% of ImmuCell's shares are currently sold short. Learn More on ImmuCell's current short interest.

What is a good short interest ratio for ImmuCell?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ICCC shares currently have a short interest ratio of 1.0. Learn More on ImmuCell's short interest ratio.

What is a good short interest percentage for ImmuCell?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.11% of ImmuCell's floating shares are currently sold short.

Is ImmuCell's short interest increasing or decreasing?

ImmuCell saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 6,100 shares, a decline of 4.7% from the previous total of 6,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is ImmuCell's float size?

ImmuCell currently has issued a total of 7,750,000 shares. Some of ImmuCell's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ImmuCell currently has a public float of 5,550,000 shares.

How does ImmuCell's short interest compare to its competitors?

0.11% of ImmuCell's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to ImmuCell: Aspira Women's Health Inc. (2.14%), ARCA biopharma, Inc. (1.37%), OncoCyte Co. (2.36%), Cardio Diagnostics Holdings, Inc. (2.53%), Trinity Biotech plc (0.02%), Biomerica, Inc. (0.40%), Alpha Teknova, Inc. (0.45%), Achieve Life Sciences, Inc. (2.09%), SeaStar Medical Holding Co. (6.83%), Marker Therapeutics, Inc. (1.68%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short ImmuCell stock?

Short selling ICCC is an investing strategy that aims to generate trading profit from ImmuCell as its price is falling. ICCC shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ImmuCell?

A short squeeze for ImmuCell occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ICCC, which in turn drives the price of the stock up even further.

How often is ImmuCell's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ICCC, twice per month. The most recent reporting period available is March, 31 2024.

More Short Interest Resources from MarketBeat

This page (NASDAQ:ICCC) was last updated on 4/23/2024 by Staff

From Our Partners